ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 36065261

The In Vitro Effect of Psoralen on Glioma Based on Network Pharmacology and Potential Target Research.

Wu Y and 4 others. Evid Based Complement Alternat Med, 2022. Cited by 8 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The In Vitro Effect of Psoralen on Glioma Based on Network Pharmacology and Potential Target Research. Papers, record 36065261. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36065261

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The In Vitro Effect of Psoralen on Glioma Based on Network Pharmacology and Potential Target Research.
PubMed
Journal
Evid Based Complement Alternat Med
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.89
iCite
Revised in PubMed
2026-01-12
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wu YYang
2Zhang YZYong-Zheng
3Li MJMeng-Jia
4Yang WQWen-Qing
5Cheng LFLu-Fenghttps://orcid.org/0000-0003-3831-6214

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Erratum in41,522,784Correction to "The In Vitro Effect of Psoralen on Glioma Based on Network Pharmacology and Potential Target Research".https://conductscience.org/library/papers/41522784

Source PubMed

References29

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122,236,189Deregulated signaling pathways in glioblastoma multiforme: molecular mechanisms and therapeutic targets.Cancer Invest2012https://conductscience.org/library/papers/22236189PubMed
229,975,751PIK3CA missense mutations promote glioblastoma pathogenesis, but do not enhance targeted PI3K inhibition.PLoS One2018https://conductscience.org/library/papers/29975751PubMed
319,629,070Targeting PI3K signalling in cancer: opportunities, challenges and limitations.Nat Rev Cancer2009https://conductscience.org/library/papers/19629070PubMed
432,348,216Psoralen: A Biologically Important Coumarin with Emerging Applications.Mini Rev Med Chem2020https://conductscience.org/library/papers/32348216PubMed
534,904,774Ivermectin accelerates autophagic death of glioma cells by inhibiting glycolysis through blocking GLUT4 mediated JAK/STAT signaling pathway activation.Environ Toxicol2022https://conductscience.org/library/papers/34904774PubMed
629,016,844PIK3CB/p110β is a selective survival factor for glioblastoma.Neuro Oncol2018https://conductscience.org/library/papers/29016844PubMed
731,036,078PIK3CA activating mutations are associated with more disseminated disease at presentation and earlier recurrence in glioblastoma.Acta Neuropathol Commun2019https://conductscience.org/library/papers/31036078PubMed
830,568,303Actively personalized vaccination trial for newly diagnosed glioblastoma.Nature2019https://conductscience.org/library/papers/30568303PubMed
930,582,752Phosphatidylinositol 3-kinase pathway genomic alterations in 60,991 diverse solid tumors informs targeted therapy opportunities.Cancer2019https://conductscience.org/library/papers/30582752PubMed
1031,227,792Genetic and molecular epidemiology of adult diffuse glioma.Nat Rev Neurol2019https://conductscience.org/library/papers/31227792PubMed

1 to 10 of 29

See all 29 references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
42,904,218Combination Therapeutic Effect of Psoralen and Paclitaxel-Loaded Superparamagnetic Iron Oxide Nanoparticles for the Treatment of Triple-Negative Breast Cancer.Int J Nanomedicine2026https://conductscience.org/library/papers/42904218PubMed
41,522,784Correction to "The In Vitro Effect of Psoralen on Glioma Based on Network Pharmacology and Potential Target Research".Evid Based Complement Alternat Med2025https://conductscience.org/library/papers/41522784PubMed
41,307,878A novel inositol phosphate metabolism signature predicts survival prognosis in low grade glioma.Discov Oncol2025https://conductscience.org/library/papers/41307878PubMed
40,841,966An exhaustive examination of the research progress in identifying potential JAK inhibitors from natural products: a comprehensive overview.Chin Med2025https://conductscience.org/library/papers/40841966PubMed
39,161,897Anti-tumor effect and hepatotoxicity mechanisms of psoralen.Front Pharmacol2024https://conductscience.org/library/papers/39161897PubMed
37,675,821Unraveling the signaling mechanism behind astrocytoma and possible therapeutics strategies: A comprehensive review.Cancer Rep (Hoboken)2023https://conductscience.org/library/papers/37675821PubMed

Genes19

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
ANXA5308PubTator's text mininghttps://conductscience.org/library/genes/308NCBI Gene
CTNNB11,499PubTator's text mininghttps://conductscience.org/library/genes/1499NCBI Gene
GAPDH2,597PubTator's text mininghttps://conductscience.org/library/genes/2597NCBI Gene
IL63,569PubTator's text mininghttps://conductscience.org/library/genes/3569NCBI Gene
JAK23,717PubTator's text mininghttps://conductscience.org/library/genes/3717NCBI Gene
MAPK45,596PubTator's text mininghttps://conductscience.org/library/genes/5596NCBI Gene
PIK3CA5,290PubTator's text mininghttps://conductscience.org/library/genes/5290NCBI Gene
PIK3CB5,291PubTator's text mininghttps://conductscience.org/library/genes/5291NCBI Gene
PIK3CD5,293PubTator's text mininghttps://conductscience.org/library/genes/5293NCBI Gene

1 to 10 of 19

See all 19 genes

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36065261

GET https://conductscience.org/api/papers/v1/36065261/references?page=2

API referenceFor AI assistants